Sonic Incytes
Vancouver
About Sonic Incytes
Sonic Incytes is the developer of Velacur, the first handheld diagnostic solution called Velacur for assessing liver attenuation with ultrasound, and liver stiffness with technology similar to that of MRI elastography, the current non-invasive gold standard. It aids in the clinical management of patients with liver disease, with measurements you can count on.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $10.6M
- Last round: Series Unknown (Oct 2025)
- Website: sonicincytes.com
- Phone: [email protected]
Industries & Categories
Health Care, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/sonic-incytes-128851 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.